Azacytidine During Anti-tuberculosis Therapy

Stopped The study was halted prematurely due to Bristol-Myers Squibb's (BMS) decision to withdraw support for this study.

Conditions

• Tuberculosis, Pulmonary

Interventions

• DRUG: Azacitidine Injection

Sponsor

Andrew Dinardo

Collaborators

• [object Object]